Form 8-K - Current report:
SEC Accession No. 0001104659-25-021954
Filing Date
2025-03-10
Accepted
2025-03-10 07:00:28
Documents
15
Period of Report
2025-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258629d1_8k.htm   iXBRL 8-K 37008
2 EXHIBIT 10.1 tm258629d1_ex10-1.htm EX-10.1 21570
3 EXHIBIT 10.2 tm258629d1_ex10-2.htm EX-10.2 22274
  Complete submission text file 0001104659-25-021954.txt   263711

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gdnsf-20250306.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdnsf-20250306_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdnsf-20250306_pre.xml EX-101.PRE 22372
18 EXTRACTED XBRL INSTANCE DOCUMENT tm258629d1_8k_htm.xml XML 3345
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 25722116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)